G-455A polymorphism of β-fibrinogen gene and the risk of premature myocardial infarction in Greece

Thrombosis Research

Volumn 125, Issue 1, 2010, Pages 34-37

  Rallidis, Loukianos S ^a   Gialeraki, Argyri ^a   Fountoulaki, Katerina ^a   Politou, Marianna ^a   Sourides, Vassilis ^a   Travlou, Anthi ^a   Lekakis, Ioannis ^a   Kremastinos, Dimitrios T ^a  

^a NATIONAL AND KAPODISTRIAN UNIVERSITY OF ATHENS   (Greece)

Author keywords

fibrinogen; G 455A polymorphism of fibrinogen; premature myocardial infarction; risk factors

Indexed keywords

FIBRINOGEN;

ADULT; ALLELE; ARTICLE; CONTROLLED STUDY; DNA HYBRIDIZATION; DNA POLYMORPHISM; FEMALE; FIBRINOGEN BLOOD LEVEL; GENETIC RISK; GENOTYPE; GREECE; HEART INFARCTION; HETEROZYGOTE; HUMAN; LIPID BLOOD LEVEL; MAJOR CLINICAL STUDY; MALE; PATHOGENESIS; POLYMERASE CHAIN REACTION; PREVALENCE; PRIORITY JOURNAL; RISK ASSESSMENT;

ADULT; AGE OF ONSET; ALLELES; CORONARY DISEASE; FEMALE; FIBRINOGEN; GENOTYPE; GREECE; HUMANS; MALE; MYOCARDIAL INFARCTION; ODDS RATIO; POLYMERASE CHAIN REACTION; POLYMORPHISM, GENETIC; RISK; RISK FACTORS;

EID: 76649127033     PISSN: 00493848     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.thromres.2009.02.017     Document Type: Article

References (34)

1. Yu S., Sher B., Kudryk B., and Redman C.M. Intracellular assembly of human fibrinogen. J Biol Chem 258 (1983) 13407-13410
2. Roy S.N., Mukhopadhyay G., and Redman C.M. Regulation of fibrinogen assembly. Transfection of Hep G2 cells with B beta cDNA specifically enhances synthesis of the three component chains of fibrinogen. J Biol Chem 265 (1990) 6389-6393
3. Humphries S.E., Henry J.A., and Montgomery H.E. Gene-environment interaction in the determination of levels of haemostatic variables involved in thrombosis and fibrinolysis. Blood Coagul Fibrinolysis 10 Suppl 1 (1999) S17-S21
4. Kamath S., and Lip G.Y. Fibrinogen: biochemistry, epidemiology and determinants. QJM 96 (2003) 711-729
5. Kannel W.B., Wolf P.A., Castelli W.P., and D'Agostino R.B. Fibrinogen and risk of cardiovascular disease. The Framingham Study. JAMA 258 (1987) 1183-1186
6. Maresca G., Di Blasio A., Marchioli R., and Di Minno G. Measuring plasma fibrinogen to predict stroke and myocardial infarction: an update. Arterioscler Thromb Vasc Biol. 19 (1999) 1368-1377
7. Paraskevas K.I., Baker D.M., Vrentzos G.E., and Mikhailidis D.P. The role of fibrinogen and fibrinolysis in peripheral arterial disease. Thromb Res 122 (2008) 1-12
8. Abrignani M.G., Novo G., Di Girolamo A., Caruso R., Tantillo R., Braschi A., et al. Increased plasma levels of fibrinogen in acute and chronic ischemic coronary syndromes. Cardiologia 44 (1999) 1047-1052
9. Zimmerman F.H., Cameron A., Fisher L.D., and Ng G. Myocardial infarction in young adults: angiographic characterization, risk factors and prognosis (Coronary Artery Surgery Study Registry). J Am Coll Cardiol 26 (1995) 654-661
10. Rallidis L.S., Belesi C.I., Manioudaki H.S., Chatziioakimidis V.K., Fakitsa V.C., Sinos L.E., et al. Myocardial infarction under the age of 36: prevalence of thrombophilic disorders. Thromb Haemost 90 (2003) 272-278
11. Marenberg M.E., Risch N., Berkman L.F., Floderus B., and de Faire U. Genetic susceptibility to death from coronary heart disease in a study of twins. N Engl J Med 330 (1994) 1041-1046
12. Morgan T.M., Krumholz H.M., Lifton R.P., and Spertus J.A. Nonvalidation of reported genetic risk factors for acute coronary syndrome in a large-scale replication study. JAMA 297 (2007) 1551-1561
13. Tybjaerg-Hansen A., Agerholm-Larsen B., Humphries S.E., Abildgaard S., Schnohr P., and Nordestgaard B.G. A common mutation (G-455 -> A) in the beta-fibrinogen promoter is an independent predictor of plasma fibrinogen, but not of ischemic heart disease. A study of 9,127 individuals based on the Copenhagen City Heart Study. J Clin Invest 99 (1997) 3034-3039
14. Leander K., Wiman B., Hallqvist J., Falk G., and De Faire U. The G-455A polymorphism of the fibrinogen Bβ-gene relates to plasma fibrinogen in male cases, but does not interact with environmental factors in causing myocardial infarction in either men or women. J Intern Med 252 (2002) 332-341
15. Folsom A.R., Aleksic N., Ahn C., Boerwinkle E., and Wu K.K. Beta-fibrinogen gene -455G/A polymorphism and coronary heart disease incidence: the Atherosclerosis Risk in Communities (ARIC) Study. Ann Epidemiol 11 (2001) 166-170
16. Boekholdt S.M., Bijsterveld N.R., Moons A.H., Levi M., Bulller H.R., and Peters R.J. Genetic variation in coagulation and fibrinolytic proteins and their relation with acute myocardial infarction: a systematic review. Circulation 104 (2001) 3063-3068
17. Atherosclerosis, Thrombosis, and Vascular Biology Italian Study Group. No evidence of association between prothrombotic gene polymorphisms and the development of acute myocardial infarction at a young age. Circulation 107 (2003) 1117-1122
18. Pegoraro R.J., Ranjith N., and Rom L. Coagulation gene polymorphisms as risk factors for myocardial infarction in young Indian Asians. Cardiovasc J South Afr 16 (2005) 152-157
19. Nomenclature and criteria for diagnosis of ischemic heart disease. Report of the Joint International Society and Federation of Cardiology/World Health Organization task force on standardization of clinical nomenclature. Circulation 59 (1979) 607-609
20. Choudhury I., and Marsh J.D. Myocardial infarction in young patients. Am J Med 107 (1999) 254-261
21. Speidl W.S., Nikfardjam M., Niessner A., Jordanova N., Zorn G., Maurer G., et al. Premature compared with late onset of coronary artery disease: young patients show a severe defect in fibrinolytic response to venous occlusion. Blood Coagul Fibrinolysis 18 (2007) 165-171
22. Bi S., Wang D., Li G., Wen S., and Pan S. Beta-fibrinogen promoter - 455 G/A (HaeIII) polymorphism prediction of plasma fibrinogen but not of ischemic cerebrovascular disease. Chin Med Sci J 19 (2004) 1-5
23. Lee A.J., Fowkes F.G., Lowe G.D., Connor J.M., and Rumley A. Fibrinogen, factor VII and PAI-1 genotypes and the risk of coronary and peripheral atherosclerosis: Edinburgh Artery Study. Thromb Haemost 81 (1999) 553-560
24. de Maat M.P., Kastelein J.J., Jukema J.W., Zwinderman A.H., Jansen H., Groenemeier B., et al. - 455G/A polymorphism of the beta-fibrinogen gene is associated with the progression of coronary atherosclerosis in symptomatic men: proposed role for an acute-phase reaction pattern of fibrinogen. REGRESS group. Arterioscler Thromb Vasc Biol 18 (1998) 265-271
25. van 't Hooft F.M., von Bahr S.J., Silveira A., Iliadou A., Eriksson P., and Hamsten A. Two common, functional polymorphisms in the promoter region of the beta-fibrinogen gene contribute to regulation of plasma fibrinogen concentration. Arterioscl Thromb Vasc Biol 19 (1999) 3063-3070
26. Humphries S.E. Genetic regulation of fibrinogen. Eur Heart J 16 (1995) 16-19 [Suppl A]
27. Endler G., and Mannhalter C. Polymorphisms in coagulation factor genes and their impact on arterial and venous thrombosis. Clin Chim Acta 330 (2003) 31-55
28. Carter A.M., Mansfield M.W., Stickland M.H., and Grant P.J. Beta-fibrinogen gene-455 G/A polymorphism and fibrinogen levels. Risk factors for coronary artery disease in subjects with NIDDM. Diabetes Care 19 (1996) 1265-1268
29. Meade T.W., Chakrabarti R., Haines A.P., North W.R., and Stirling Y. Characteristics affecting fibrinolytic activity and plasma fibrinogen concentrations. Br Med J 1 (1979) 153-156
30. Humphries S.E., Ye S., Talmud P., Bara L., Wilhelmsen L., and Tiret L. European Atherosclerosis Research Study: genotype at the fibrinogen locus (G-455-A beta-gene) is associated with differences in plasma fibrinogen levels in young men and women from different regions in Europe. Evidence for gender-genotype-environment interaction. Arterioscler Thromb Vasc Biol 15 (1995) 96-104
31. Green F., Hamsten A., Blomback M., and Humphries S. The role of beta-fibrinogen genotype in determining plasma fibrinogen levels in young survivors of myocardial infarction and healthy controls from Sweden. Thromb Haemost 70 (1993) 915-920
32. Mähönen M.S., McElduff P., Dobson A.J., Kuulasmaa K.A., Evans A.E., and WHO MONICA Project. Current smoking and the risk of non-fatal myocardial infarction in the WHO MONICA Project populations. Tob Control 13 (2004) 244-250
33. Panagiotakos D.B., Rallidis L.S., Pitsavos C., Stefanadis C., and Kremastinos D. Cigarette smoking and myocardial infarction in young men and women; a case-control study. Int J Cardiol 116 (2007) 371-375
34. Rallidis L.S., Panagiotakos D.B., Pitsavos C., Stefanadis C., and Kremastinos D.T. Effects of smoking on myocardial infarction in young people. Int J Cardiol 120 (2007) 136-137